Teleflex completed the acquisition of Z-Medica from Linden Capital and DW Healthcare Partners for $525m.

Teleflex, a global provider for healthcare supplies and services, completed the acquisition of Z-Medica, a manufacturer of hemostatic products, from investment firms Linden Capital and DW Healthcare Partners for $525m. "We are excited to join the Teleflex organization, which shares our vision for making our products the standard of care for the treatment of hemorrhage control. Today's announcement is a recognition of our focus on patient outcomes and the hard work and dedication of the entire Z-Medica team. I want to especially thank Linden Capital Partners and DW Healthcare Partners, who supported Z-Medica to expand from its roots in the military to become a true global healthcare and hospital focused business. We have tremendous respect for the Teleflex team and look forward to partnering with them to continue changing patient lives," Eric Compton, Z-Medica President and CEO.